recombinant human thyroid stimulating hormone for injection (rhTSH) / Suzhou Zelgen 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
recombinant human thyroid stimulating hormone for injection (rhTSH) / Suzhou Zelgen
NCT04971473: Comparison of the Efficacy and Safety of rhTSH as An Adjunctive Diagnostic Tool in Differentiated Thyroid Cancer Patients Who Had Been Thyroidectomized Vs. Patients Who After Thyroid Hormone Withdrawal

Completed
3
201
RoW
rhTSH, recombinant human thyroid stimulating hormone
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Differentiated Thyroid Cancer
07/23
07/23
NCT04964284: Efficacy and Safety Study of rhTSH for Adjuvant Radioiodine Ablation Therapy in Patients With Differentiated Thyroid Cancer

Recruiting
3
328
RoW
rhTSH, Recombinant human thyroid-stimulating hormone, Radioiodine (131I)
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Differentiated Thyroid Cancer
09/24
12/24
NCT04447183: The Safety and Effectiveness of rhTSH in Radioiodine Treatment for Patients With Differentiated Thyroid Cancer.

Active, not recruiting
2
120
RoW
Recombinant Human Thyroid Stimulating Hormone for Injection(rhTSH), radioactive iodine
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Differentiated Thyroid Cancer
08/24
10/24

Download Options